FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4360950905> ?p ?o ?g. }

• W4360950905 endingPage "17" @default.
• W4360950905 startingPage "10" @default.
• W4360950905 abstract "This study aims to compare the strategies fludarabine, cyclophosphamide, and rituximab and fludarabine and cyclophosphamide for the treatment of chronic lymphocytic leukemia in Brazil.A three-states clock-reset semi-Markovian model was constructed in R. The time horizon of the analysis was 15 years and monthly cycles were used. Transition probabilities were derived from the survival curves of the CLL-8 study. Other probabilities were also derived from the medical literature. Costs included in the model referred to the application of injectable drugs, prescription cost, cost of treating adverse events, and costs of supportive care. The model was evaluated by microsimulation. To determine the study result, multiple cost-effectiveness threshold values were used.In the main analysis, an incremental cost-effectiveness ratio of 19 029.38 PPP-US dollars (USD)/quality-adjusted life-year (QALY) (41 141.52 Brazilian real/QALY) was observed. In 1.8% of the iterations, fludarabine and cyclophosphamide was considered dominant over fludarabine, cyclophosphamide, and rituximab. It can be shown that at 1 gross domestic product (GDP) per capita/QALY, 36.1% of the iterations would consider the technology cost-effective. At 2 GDP per capita/QALY, this number rises to 82.1%. At 50 000 USD/QALY, 92.8% of the iterations would suggest the technology to be cost-effective. In terms of some threshold accepted or proposed around the world, the technology would be considered cost-effective at 50 000 USD/QALY, 3 GDP per capita/QALY, and 2 GDP per capita/QALY. It would not be cost-effective at 1 GDP per capita/QALY or the opportunity costs threshold.It can be considered that rituximab is cost-effective for the treatment of chronic lymphocytic leukemia in Brazil." @default.
• W4360950905 created "2023-03-26" @default.
• W4360950905 creator A5037652307 @default.
• W4360950905 creator A5044379309 @default.
• W4360950905 creator A5052539371 @default.
• W4360950905 creator A5055460628 @default.
• W4360950905 creator A5062883645 @default.
• W4360950905 creator A5074165396 @default.
• W4360950905 creator A5077386852 @default.
• W4360950905 creator A5082283472 @default.
• W4360950905 date "2023-07-01" @default.
• W4360950905 modified "2023-10-04" @default.
• W4360950905 title "Cost-Effectiveness Analysis of Rituximab for Chronic Lymphocytic Leukemia Using A Semi-Markovian Model Approach in R" @default.
• W4360950905 cites W1243376384 @default.
• W4360950905 cites W1860521168 @default.
• W4360950905 cites W1969214982 @default.
• W4360950905 cites W1969837687 @default.
• W4360950905 cites W1977585061 @default.
• W4360950905 cites W1978454290 @default.
• W4360950905 cites W1990522507 @default.
• W4360950905 cites W1993986769 @default.
• W4360950905 cites W2010913334 @default.
• W4360950905 cites W2020013501 @default.
• W4360950905 cites W2024250991 @default.
• W4360950905 cites W2024491306 @default.
• W4360950905 cites W2038107959 @default.
• W4360950905 cites W2053438894 @default.
• W4360950905 cites W2057847137 @default.
• W4360950905 cites W2060552273 @default.
• W4360950905 cites W2072371345 @default.
• W4360950905 cites W2079188511 @default.
• W4360950905 cites W2088030566 @default.
• W4360950905 cites W2095745169 @default.
• W4360950905 cites W2121913400 @default.
• W4360950905 cites W2122664355 @default.
• W4360950905 cites W2123052393 @default.
• W4360950905 cites W2136951425 @default.
• W4360950905 cites W2140606816 @default.
• W4360950905 cites W2141880470 @default.
• W4360950905 cites W2145796979 @default.
• W4360950905 cites W2151177887 @default.
• W4360950905 cites W2156617860 @default.
• W4360950905 cites W2181233858 @default.
• W4360950905 cites W2221262359 @default.
• W4360950905 cites W2270054845 @default.
• W4360950905 cites W2286756681 @default.
• W4360950905 cites W2291155501 @default.
• W4360950905 cites W2294046808 @default.
• W4360950905 cites W2308780747 @default.
• W4360950905 cites W2323490326 @default.
• W4360950905 cites W2337377794 @default.
• W4360950905 cites W2337485820 @default.
• W4360950905 cites W2337912831 @default.
• W4360950905 cites W2430283214 @default.
• W4360950905 cites W2501112626 @default.
• W4360950905 cites W2507587328 @default.
• W4360950905 cites W2507965260 @default.
• W4360950905 cites W2516994167 @default.
• W4360950905 cites W2518649063 @default.
• W4360950905 cites W2542111280 @default.
• W4360950905 cites W2553911513 @default.
• W4360950905 cites W2599980044 @default.
• W4360950905 cites W2744781811 @default.
• W4360950905 cites W2761236690 @default.
• W4360950905 cites W2779167403 @default.
• W4360950905 cites W2782210394 @default.
• W4360950905 cites W2789093098 @default.
• W4360950905 cites W2790385276 @default.
• W4360950905 cites W2902484351 @default.
• W4360950905 cites W2964876593 @default.
• W4360950905 cites W2985508865 @default.
• W4360950905 cites W2987606426 @default.
• W4360950905 cites W3016538158 @default.
• W4360950905 cites W3096933788 @default.
• W4360950905 cites W4206608028 @default.
• W4360950905 cites W4250814457 @default.
• W4360950905 cites W4251009301 @default.
• W4360950905 cites W4294236195 @default.
• W4360950905 doi "https://doi.org/10.1016/j.vhri.2023.01.011" @default.
• W4360950905 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36966699" @default.
• W4360950905 hasPublicationYear "2023" @default.
• W4360950905 type Work @default.
• W4360950905 citedByCount "0" @default.
• W4360950905 crossrefType "journal-article" @default.
• W4360950905 hasAuthorship W4360950905A5037652307 @default.
• W4360950905 hasAuthorship W4360950905A5044379309 @default.
• W4360950905 hasAuthorship W4360950905A5052539371 @default.
• W4360950905 hasAuthorship W4360950905A5055460628 @default.
• W4360950905 hasAuthorship W4360950905A5062883645 @default.
• W4360950905 hasAuthorship W4360950905A5074165396 @default.
• W4360950905 hasAuthorship W4360950905A5077386852 @default.
• W4360950905 hasAuthorship W4360950905A5082283472 @default.
• W4360950905 hasConcept C112930515 @default.
• W4360950905 hasConcept C126322002 @default.
• W4360950905 hasConcept C127598652 @default.
• W4360950905 hasConcept C2776694085 @default.
• W4360950905 hasConcept C2776755627 @default.
• W4360950905 hasConcept C2779263901 @default.

• next